CompanyCore
UK company intelligence
Company profile report
Prepared 14 July 2026
AMBER THERAPEUTICS HOLDINGS LIMITED
13089338 · ltd · incorporated 2020-12-18
1. Company facts
- Status
- active
- Lifecycle
- 🏛️ Established — Profitable, stable, 5+ years of trading. Classic SME profile.
- Jurisdiction
- england-wales
- Registered office
- Unit 1 Tech Foundry 2, Curie Avenue, Didcot, OX11 0QQ, England
- SIC codes
- 72110 — Research and experimental development on biotechnology
- Accounts next due
- 2026-09-30
- Confirmation statement next due
- 2026-12-31
2. Directors (6 active)
- AMERSON, David Rogers
- director · appointed 2025-04-15 · born 12/1962 (age 64)
- BUTLER, Caroline
- director · appointed 2024-05-23 · born 2/1980 (age 46)
- CHAMAS, Liliane, Doctor
- director · appointed 2021-06-18 · born 10/1986 (age 40)
- CHU, Yen-Min Kevin
- director · appointed 2024-05-23 · born 2/1989 (age 37)
- CRAWLEY, Aidan Harold Winston
- director · appointed 2020-12-18 · born 10/1983 (age 43)
- LE, Tiffany
- director · appointed 2024-05-23 · born 6/1990 (age 36)
3. Shareholders (1 active)
- Oxford Science Enterprises Holdings Ii Limited
- 25-50% shares · 25-50% voting
4. Group structure
Oxford Science Enterprises Holdings Ii Limited holds 25-50% — a significant corporate investor but not a controlling parent.
- Oxford Science Enterprises Holdings Ii Limited
- Corporate parent · 25-50%
Headline verdict
- Opportunity score
- 76/100 (Strong)
- Owner dependency
- moderate — 48/100
- Red flags
- 0 high · 0 medium · 0 low